Boston, Massachusetts
United States
70
2026-05-21
The entities that hold a legal rights for patent applications filed by inventor LOEW Andreas:
Andreas LOEW from Boston, US has applied for patents for these inventions. The list has both pending applications and granted patents:
TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR
#2 | 2026-03-19TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTOR
#3 | 2026-01-22ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#4 | 2025-11-06ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#5 | 2025-10-30MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELL RELATED CANCER CELLS AND USES THEREOF
#6 | 2025-07-03ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#7 | 2025-03-27MULTISPECIFIC MOLECULES BINDING TO TCR AND USES THEREOF
#8 | 2025-03-06MULTIFUNCTIONAL MOLECULES AND USES THEREOF
#9 | 2025-01-09HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#10 | 2025-01-09MULTIFUNCTIONAL MOLECULES COMPRISING G6B BINDER AND/OR CD34 BINDER AND USES THEREOF
#11 | 2024-09-26TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY
#12 | 2024-09-12ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#13 | 2024-09-05HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#14 | 2024-07-18TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR
#15 | 2024-03-14TREATMENT OF CANCER USING CHIMERIC CD3 RECEPTOR PROTEINS
#16 | 2024-03-07ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#17 | 2024-01-04MULTIFUNCTIONAL MOLECULES THAT BIND TO CALRETICULIN AND USES THEREOF
#18 | 2023-11-23ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#19 | 2023-11-23CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING CELL
#20 | 2023-11-09MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELL RELATED CANCER CELLS AND USES THEREOF
#21 | 2023-11-02ANTIBODY MOLECULES THAT BIND TO NKP30 AND USES THEREOF
#22 | 2023-10-19METHODS OF DETECTING TRBC1 OR TRBC2
#23 | 2023-08-31MULTISPECIFIC ANTIBODY MOLECULES COMPRISINGLAMBDA AND KAPPA LIGHT CHAINS
#24 | 2023-08-31Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules
#25 | 2023-07-20ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#26 | 2023-07-13TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
#27 | 2023-06-22ENGINEERED CELL COMPOSITIONS AND METHODS OF USE THEREOF
#28 | 2023-06-08Anti-TCR antibody molecules and uses thereof
#29 | 2023-05-11ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#30 | 2023-04-27ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#31 | 2023-03-30MULTIFUNCTIONAL MOLECULES THAT BIND TO CD33 AND USES THEREOF
#32 | 2023-02-16ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#33 | 2023-02-02ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#34 | 2023-02-02ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#35 | 2023-01-26REGULATABLE CHIMERIC ANTIGEN RECEPTOR
#36 | 2023-01-26ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#37 | 2022-12-01DIMERIZATION SWITCHES AND USES THEREOF
#38 | 2022-09-15MULTISPECIFIC AND MULTIFUNCTIONAL MOLECULES AND USES THEREOF
#39 | 2022-06-23CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)- EXPRESSING CELL
#40 | 2022-03-03ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#41 | 2022-03-03ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#42 | 2021-12-09ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#43 | 2021-12-09MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELLS AND USES THEREOF TO TREAT AUTOIMMUNE DISORDERS
#44 | 2021-12-09MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELL RELATED CANCER CELLS AND USES THEREOF
#45 | 2021-12-09MULTIFUNCTIONAL MOLECULES THAT BIND TO CALRETICULIN AND USES THEREOF
#46 | 2021-12-02ANTIBODY MOLECULES THAT BIND TO NKP30 AND USES THEREOF
#47 | 2021-09-16TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
#48 | 2021-08-12MULTISPECIFIC MOLECULES THAT BIND TO MYELOPROLIFERATIVE LEUKEMIA (MPL) PROTEIN AND USES THEREOF
#49 | 2021-08-05Multifunctional molecules that bind to calreticulin and uses thereof
#50 | 2021-03-25REGULATABLE CHIMERIC ANTIGEN RECEPTOR
#51 | 2021-01-14MULTIFUNCTIONAL MOLECULES AND USES THEREOF
#52 | 2021-01-07Treatment of cancer using a CD123 chimeric antigen receptor
#53 | 2020-12-31Human mesothelin chimeric antigen receptors and uses thereof
#54 | 2020-12-10MULTISPECIFIC MOLECULES COMPRISING A NON-IMMUNOGLOBULIN HETERODIMERIZATION DOMAIN AND USES THEREOF
#55 | 2020-12-03Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
#56 | 2020-12-03MULTISPECIFIC MOLECULES AND USES THEREOF
#57 | 2020-09-17MULTIFUNCTIONAL MOLECULES COMPRISING A TRIMERIC LIGAND AND USES THEREOF
#58 | 2020-09-10TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTOR
#59 | 2020-03-05Multispecific molecules and uses thereof
#60 | 2019-12-12TREATMENT OF CANCER USING CHIMERIC T CELL RECEPTOR PROTEINS HAVING MULTIPLE SPECIFICITIES
#61 | 2019-10-31Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
#62 | 2019-09-26CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
#63 | 2019-08-29Regulatable chimeric antigen receptor
#64 | 2019-07-18Multispecific antibody molecules comprising lambda and kappa light chains
#65 | 2019-05-09Treatment of cancer using humanized anti-CD19 chimeric antigen receptor
#66 | 2018-11-22Yeast display systems
#67 | 2018-08-16Treatment of cancer using chimeric CD3 receptor proteins
#68 | 2018-05-10FIBRONECTIN-BASED BINDING MOLECULES AND USES THEREOF
#69 | 2018-04-19SINGLE CHAIN PROTEINS WITH C-TERMINAL MODIFICATIONS
#70 | 2017-09-14Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
2167017 ⎘